Fellowship · Sacramento, CA
Sponsored by University of California Davis Health
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause.
Expert review of clinical pharmacology · 2022 · 60 citations · Mitchell Creinin
Cesarean scar ectopic pregnancy: nuances in diagnosis and treatment.
Fertility and sterility · 2023 · 27 citations · Natalie DiCenzo
Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia.
BJOG : an international journal of obstetrics and gynaecology · 2022 · 47 citations · Mitchell Creinin
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.
Contraception · 2021 · 49 citations · Mitchell Creinin, Melissa Chen
Estetrol/Drospirenone safety in a population with cardiovascular risk factors.
Contraception · 2025 · 10 citations · Mitchell Creinin
Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine.
Contraception · 2024 · 10 citations ·
Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine.
American journal of obstetrics and gynecology · 2025 · 9 citations · Blake Zwerling
Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4).
Frontiers in global women's health · 2024 · 16 citations · Mitchell Creinin